Seeger, Robert C.
University of Southern California · Children's Hospital Los Angeles · Saban Research Institute
6 papers on CoChatORCID 0000-0001-7242-0918
Most cited papers
- Verified
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., et al. (2010) · New England Journal of Medicine
Neuroblastoma Research and TreatmentsGlioma Diagnosis and Treatment
Cited by 1,835
- Verified
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
Matthay, K. K., Reynolds, C. P., Seeger, R. C., Shimada, H., Adkins, E. S., Haas-Kogan, D., Gerbing, R. B., London, W. B., & Villablanca, J. G. (2009) · Journal of Clinical Oncology
Neuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma Cases
Cited by 858
- Verified
Prognostic Significance of Gene Expression Profiles of Metastatic Neuroblastomas Lacking MYCN Gene Amplification
Asgharzadeh, S., Pique-Regi, R., Sposto, R., Wang, H., Yang, Y., Shimada, H., Matthay, K., Buckley, J., Ortega, A., & Seeger, R. C. (2006) · JNCI: Journal of the National Cancer Institute
Neuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma Cases
Cited by 237
- Verified
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells
Ara, T., Song, L., Shimada, H., Keshelava, N., Russell, H. V., Metelitsa, L. S., Groshen, S. G., Seeger, R. C., & DeClerck, Y. A. (2009) · Cancer Research
Neuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma Cases
Cited by 175
- Verified
Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
Oberthuer, A., Hero, B., Berthold, F., Juraeva, D., Faldum, A., Kahlert, Y., Asgharzadeh, S., Seeger, R., Scaruffi, P., Tonini, G. P., et al. (2010) · Journal of Clinical Oncology
Neuroblastoma Research and TreatmentsBreast Cancer Treatment Studies
Cited by 135
- Verified
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma
Zhang, S., Wei, J. S., Li, S. Q., Badgett, T. C., Song, Y. K., Agarwal, S., Coarfa, C., Tolman, C., Hurd, L., Liao, H., et al. (2016) · Cancer Letters
Neuroblastoma Research and TreatmentsRNA Research and Splicing
Cited by 58
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free